1887

Abstract

Different definitions of the terms multidrug-resistant (MDR) and pandrug-resistant (PDR) and have been used in the biomedical literature. The authors searched for relevant studies indexed in the PubMed database (01/2000–09/2005) to systematically examine the various definitions of MDR and PDR for these bacteria. Initially 107 retrieved relevant studies were reviewed. Ninety-two studies were further analysed, 50 of which focused on and 42 on . A considerable diversity of definitions of the terms MDR and PDR and was found. Of note, the term PDR was inappropriately used in all five studies that used it. The review reveals that various definitions have been used for the terms MDR and PDR and , a fact that causes confusion to researchers and clinicians. The authors believe that at least a widely accepted definition for PDR and should be uniformly used worldwide.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.46747-0
2006-12-01
2019-11-17
Loading full text...

Full text loading...

/deliver/fulltext/jmm/55/12/1619.html?itemId=/content/journal/jmm/10.1099/jmm.0.46747-0&mimeType=html&fmt=ahah

References

  1. Abbo, A., Navon-Venezia, S., Hammer-Muntz, O., Krichali, T., Siegman-Igra, Y. & Carmeli, Y. ( 2005; ). Multidrug-resistant Acinetobacter baumannii. Emerg Infect Dis 11, 22–29.[CrossRef]
    [Google Scholar]
  2. Ahmed, N., Bal, A., Khan, A. A. & 9 other authors ( 2002; ). Whole genome fingerprinting and genotyping of multiple drug resistant (MDR) isolates of Pseudomonas aeruginosa from endophthalmitis patients in India. Infect Genet Evol 1, 237–242.[CrossRef]
    [Google Scholar]
  3. Alarcon, T., Lopez-Hernandez, S., Andreu, D., Saugar, J. M., Rivas, L. & Lopez-Brea, M. ( 2001; ). In vitro activity of CA(1-8)M(1-18), a synthetic cecropin A-melittin hybrid peptide, against multiresistant Acinetobacter baumannii strains. Rev Esp Quimioter 14, 184–190.
    [Google Scholar]
  4. Appleman, M. D., Belzberg, H., Citron, D. M., Heseltine, P. N., Yellin, A. E., Murray, J. & Berne, T. V. ( 2000; ). In vitro activities of nontraditional antimicrobials against multiresistant Acinetobacter baumannii strains isolated in an intensive care unit outbreak. Antimicrob Agents Chemother 44, 1035–1040.[CrossRef]
    [Google Scholar]
  5. Belet, N., Haciomeroglu, P. & Kucukoduk, S. ( 2004; ). Ciprofloxacin treatment in newborns with multi-drug-resistant nosocomial Pseudomonas infections. Biol Neonate 85, 263–268.[CrossRef]
    [Google Scholar]
  6. Blahova, J., Kralikova, K., Krcmery, V., Sr, Kubonova, K., Vaculikova, A., Mikovicova, A., Klokocnikova, L., Hanzen, J. & Jezek, P. ( 2001; ). Transferable antibiotic resistance in multiresistant nosocomial Acinetobacter baumannii strains from seven clinics in the Slovak and Czech Republics. J Chemother 13, 143–147.[CrossRef]
    [Google Scholar]
  7. Bou, G., Cervero, G., Dominguez, M. A., Quereda, C. & Martinez-Beltran, J. ( 2000; ). Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of beta-lactamases. J Clin Microbiol 38, 3299–3305.
    [Google Scholar]
  8. Bratu, S., Quale, J., Cebular, S., Heddurshetti, R. & Landman, D. ( 2005; ). Multidrug-resistant Pseudomonas aeruginosa in Brooklyn, New York: molecular epidemiology and in vitro activity of polymyxin B. Eur J Clin Microbiol Infect Dis 24, 196–201.[CrossRef]
    [Google Scholar]
  9. Brito, D. V., Oliveira, E. J., Matos, C., Abdallah, V. O. & Gontijo Filho, P. P. ( 2003; ). An outbreak of conjunctivitis caused by multiresistant Pseudomonas aeruginosa in a Brazilian newborn intensive care unit. Braz J Infect Dis 7, 234–235.[CrossRef]
    [Google Scholar]
  10. Bukholm, G., Tannaes, T., Kjelsberg, A. B. & Smith-Erichsen, N. ( 2002; ). An outbreak of multidrug-resistant Pseudomonas aeruginosa associated with increased risk of patient death in an intensive care unit. Infect Control Hosp Epidemiol 23, 441–446.[CrossRef]
    [Google Scholar]
  11. Canton, R., Coque, T. M. & Baquero, F. ( 2003; ). Multi-resistant Gram-negative bacilli: from epidemics to endemics. Curr Opin Infect Dis 16, 315–325.[CrossRef]
    [Google Scholar]
  12. Cao, B., Wang, H., Sun, H., Zhu, Y. & Chen, M. ( 2004; ). Risk factors and clinical outcomes of nosocomial multi-drug resistant Pseudomonas aeruginosa infections. J Hosp Infect 57, 112–118.[CrossRef]
    [Google Scholar]
  13. Cawley, M. J., Suh, C., Lee, S. & Ackerman, B. H. ( 2002; ). Nontraditional dosing of ampicillin-sulbactam for multidrug-resistant Acinetobacter baumannii meningitis. Pharmacotherapy 22, 527–532.[CrossRef]
    [Google Scholar]
  14. Corbella, X., Montero, A., Pujol, M., Dominguez, M. A., Ayats, J., Argerich, M. J., Garrigosa, F., Ariza, J. & Gudiol, F. ( 2000; ). Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J Clin Microbiol 38, 4086–4095.
    [Google Scholar]
  15. Davies, G., McShane, D., Davies, J. C. & Bush, A. ( 2003; ). Multiresistant Pseudomonas aeruginosa in a pediatric cystic fibrosis center: natural history and implications for segregation. Pediatr Pulmonol 35, 253–256.[CrossRef]
    [Google Scholar]
  16. Defez, C., Fabbro-Peray, P., Bouziges, N., Gouby, A., Mahamat, A., Daures, J. P. & Sotto, A. ( 2004; ). Risk factors for multidrug-resistant Pseudomonas aeruginosa nosocomial infection. J Hosp Infect 57, 209–216.[CrossRef]
    [Google Scholar]
  17. Domenig, C., Traunmuller, F., Kozek, S., Wisser, W., Klepetko, W., Steininger, R., Spiss, C. & Thalhammer, F. ( 2001; ). Continuous beta-lactam antibiotic therapy in a double-lung transplanted patient with a multidrug-resistant Pseudomonas aeruginosa infection. Transplantation 71, 744–745.[CrossRef]
    [Google Scholar]
  18. Douglas, M. W., Mulholland, K., Denyer, V. & Gottlieb, T. ( 2001; ). Multi-drug resistant Pseudomonas aeruginosa outbreak in a burns unit – an infection control study. Burns 27, 131–135.[CrossRef]
    [Google Scholar]
  19. Dubois, V., Arpin, C., Melon, M., Melon, B., Andre, C., Frigo, C. & Quentin, C. ( 2001; ). Nosocomial outbreak due to a multiresistant strain of Pseudomonas aeruginosa P12: efficacy of cefepime-amikacin therapy and analysis of beta-lactam resistance. J Clin Microbiol 39, 2072–2078.[CrossRef]
    [Google Scholar]
  20. El Shafie, S. S., Alishaq, M. & Leni, G. M. ( 2004; ). Investigation of an outbreak of multidrug-resistant Acinetobacter baumannii in trauma intensive care unit. J Hosp Infect 56, 101–105.[CrossRef]
    [Google Scholar]
  21. Epstein, B. J., Gums, J. G. & Drlica, K. ( 2004; ). The changing face of antibiotic prescribing: the mutant selection window. Ann Pharmacother 38, 1675–1682.[CrossRef]
    [Google Scholar]
  22. Erdem, I., Kucukercan, M. & Ceran, N. ( 2003; ). In vitro activity of combination therapy with cefepime, piperacillin-tazobactam, or meropenem with ciprofloxacin against multidrug-resistant Pseudomonas aeruginosa strains. Chemotherapy 49, 294–297.[CrossRef]
    [Google Scholar]
  23. Falagas, M. E., Bliziotis, I. A., Kasiakou, S. K., Samonis, G., Athanassopoulou, P. & Michalopoulos, A. ( 2005; ). Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria. BMC Infect Dis 5, 24.[CrossRef]
    [Google Scholar]
  24. Fraser, T. G., Reiner, S., Malczynski, M., Yarnold, P. R., Warren, J. & Noskin, G. A. ( 2004; ). Multidrug-resistant Pseudomonas aeruginosa cholangitis after endoscopic retrograde cholangiopancreatography: failure of routine endoscope cultures to prevent an outbreak. Infect Control Hosp Epidemiol 25, 856–859.[CrossRef]
    [Google Scholar]
  25. Gales, A. C., Jones, R. N., Forward, K. R., Linares, J., Sader, H. S. & Verhoef, J. ( 2001; ). Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997–1999). Clin Infect Dis 32, S104–S113.[CrossRef]
    [Google Scholar]
  26. Garnacho-Montero, J., Ortiz-Leyba, C., Jimenez-Jimenez, F. J., Barrero-Almodovar, A. E., Garcia-Garmendia, J. L., Bernabeu-Wittell, M., Gallego-Lara, S. L. & Madrazo-Osuna, J. ( 2003; ). Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Clin Infect Dis 36, 1111–1118.[CrossRef]
    [Google Scholar]
  27. Giacometti, A., Cirioni, O., Del Prete, M. S., Barchiesi, F., Paggi, A. M., Petrelli, E. & Scalise, G. ( 2000; ). Comparative activities of polycationic peptides and clinically used antimicrobial agents against multidrug-resistant nosocomial isolates of Acinetobacter baumannii. J Antimicrob Chemother 46, 807–810.[CrossRef]
    [Google Scholar]
  28. Giamarellos-Bourboulis, E. J., Grecka, P., Dionyssiou-Asteriou, A. & Giamarellou, H. ( 2000; ). Impact of n-6 polyunsaturated fatty acids on growth of multidrug-resistant Pseudomonas aeruginosa: interactions with amikacin and ceftazidime. Antimicrob Agents Chemother 44, 2187–2189.[CrossRef]
    [Google Scholar]
  29. Giamarellos-Bourboulis, E. J., Xirouchaki, E. & Giamarellou, H. ( 2001; ). Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii. Diagn Microbiol Infect Dis 40, 117–120.[CrossRef]
    [Google Scholar]
  30. Giamarellos-Bourboulis, E. J., Kentepozidis, N., Antonopoulou, A., Plachouras, D., Tsaganos, T. & Giamarellou, H. ( 2005; ). Postantibiotic effect of antimicrobial combinations on multidrug-resistant Pseudomonas aeruginosa. Diagn Microbiol Infect Dis 51, 113–117.[CrossRef]
    [Google Scholar]
  31. Goossens, H. ( 2003; ). Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group. Clin Microbiol Infect 9, 980–983.[CrossRef]
    [Google Scholar]
  32. Gorman, S. K., Zed, P. J., Dhingra, V. K. & Ronco, J. J. ( 2003; ). Rapid imipenem/cilastatin desensitization for multidrug-resistant Acinetobacter pneumonia. Ann Pharmacother 37, 513–516.[CrossRef]
    [Google Scholar]
  33. Hamer, D. H. ( 2000; ). Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug-resistant Pseudomonas aeruginosa with aerosolized colistin. Am J Respir Crit Care Med 162, 328–330.[CrossRef]
    [Google Scholar]
  34. Harbarth, S. & Samore, M. H. ( 2005; ). Antimicrobial resistance determinants and future control. Emerg Infect Dis 11, 794–801.[CrossRef]
    [Google Scholar]
  35. Higgins, P. G., Wisplinghoff, H., Stefanik, D. & Seifert, H. ( 2004; ). In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains. Antimicrob Agents Chemother 48, 1586–1592.[CrossRef]
    [Google Scholar]
  36. Hsueh, P. R., Liu, C. Y. & Luh, K. T. ( 2002; ). Current status of antimicrobial resistance in Taiwan. Emerg Infect Dis 8, 132–137.[CrossRef]
    [Google Scholar]
  37. Hsueh, P. R., Tseng, S. P., Teng, L. J. & Ho, S. W. ( 2005; ). Pan-drug-resistant Pseudomonas aeruginosa causing nosocomial infection at a university hospital in Taiwan. Clin Microbiol Infect 11, 670–673.[CrossRef]
    [Google Scholar]
  38. Huys, G., Cnockaert, M., Vaneechoutte, M., Woodford, N., Nemec, A., Dijkshoorn, L. & Swings, J. ( 2005; ). Distribution of tetracycline resistance genes in genotypically related and unrelated multiresistant Acinetobacter baumannii strains from different European hospitals. Res Microbiol 156, 348–355.[CrossRef]
    [Google Scholar]
  39. Jain, R. & Danziger, L. H. ( 2004; ). Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians. Ann Pharmacother 38, 1449–1459.[CrossRef]
    [Google Scholar]
  40. Jiménez-Mejías, M. E., Pichardo-Guerrero, C., Márquez-Rivas, F. J., Martín-Lozano, D., Prados, T. & Pachón, J. ( 2002; ). Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis. Eur J Clin Microbiol Infect Dis 21, 212–214.[CrossRef]
    [Google Scholar]
  41. Jones, A. M., Govan, J. R., Doherty, C. J., Dodd, M. E., Isalska, B. J., Stanbridge, T. N. & Webb, A. K. ( 2001; ). Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet 358, 557–558.[CrossRef]
    [Google Scholar]
  42. Jones, R. N. ( 2003; ). Global epidemiology of antimicrobial resistance among community-acquired and nosocomial pathogens: a five-year summary from the SENTRY Antimicrobial Surveillance Program (1997–2001). Semin Respir Crit Care Med 24, 121–134.[CrossRef]
    [Google Scholar]
  43. Jones, R. N., Deshpande, L., Fritsche, T. R. & Sader, H. S. ( 2004; ). Determination of epidemic clonality among multidrug-resistant strains of Acinetobacter spp. and Pseudomonas aeruginosa in the MYSTIC Programme (USA, 1999–2003). Diagn Microbiol Infect Dis 49, 211–216.[CrossRef]
    [Google Scholar]
  44. Joshi, S. G., Litake, G. M., Niphadkar, K. B. & Ghole, V. S. ( 2003; ). Multidrug resistant Acinetobacter baumannii isolates from a teaching hospital. J Infect Chemother 9, 187–190.[CrossRef]
    [Google Scholar]
  45. Jung, R., Fish, D. N., Obritsch, M. D. & MacLaren, R. ( 2004; ). Surveillance of multi-drug resistant Pseudomonas aeruginosa in an urban tertiary-care teaching hospital. J Hosp Infect 57, 105–111.[CrossRef]
    [Google Scholar]
  46. Kocazeybek, B., Arabaci, U., Erenturk, S. & Akdur, H. ( 2002; ). Investigation of various antibiotic combinations using the E-Test method in multiresistant Pseudomonas aeruginosa strains. Chemotherapy 48, 31–35.[CrossRef]
    [Google Scholar]
  47. Kuo, L. C., Yu, C. J., Lee, L. N., Wang, J. L., Wang, H. C., Hsueh, P. R. & Yang, P. C. ( 2003; ). Clinical features of pandrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Taiwan. J Formos Med Assoc 102, 601–606.
    [Google Scholar]
  48. Kuo, L. C., Teng, L. J., Yu, C. J., Ho, S. W. & Hsueh, P. R. ( 2004; ). Dissemination of a clone of unusual phenotype of pandrug-resistant Acinetobacter baumannii at a university hospital in Taiwan. J Clin Microbiol 42, 1759–1763.[CrossRef]
    [Google Scholar]
  49. Landman, D., Quale, J. M., Mayorga, D., Adedeji, A., Vangala, K., Ravishankar, J., Flores, C. & Brooks, S. ( 2002; ). Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned. Arch Intern Med 162, 1515–1520.[CrossRef]
    [Google Scholar]
  50. Lang, B. J., Aaron, S. D., Ferris, W., Hebert, P. C. & MacDonald, N. E. ( 2000; ). Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with multiresistant strains of Pseudomonas aeruginosa. Am J Respir Crit Care Med 162, 2241–2245.[CrossRef]
    [Google Scholar]
  51. Lee, C. M., Lim, H. K., Liu, C. P. & Tseng, H. K. ( 2005; ). Treatment of pan-drug resistant Acinetobacter baumannii. Scand J Infect Dis 37, 195–199.[CrossRef]
    [Google Scholar]
  52. Levin, A. S., Gobara, S., Mendes, C. M., Cursino, M. R. & Sinto, S. ( 2001; ). Environmental contamination by multidrug-resistant Acinetobacter baumannii in an intensive care unit. Infect Control Hosp Epidemiol 22, 717–720.[CrossRef]
    [Google Scholar]
  53. Lin, Y. W., Adachi, S., Watanabe, K., Umeda, K. & Nakahata, T. ( 2003; ). Serial granulocyte transfusions as a treatment for sepsis due to multidrug-resistant Pseudomonas aeruginosa in a neutropenic patient. J Clin Microbiol 41, 4892–4893.[CrossRef]
    [Google Scholar]
  54. Ling, M. L., Ang, A., Wee, M. & Wang, G. C. ( 2001; ). A nosocomial outbreak of multiresistant Acinetobacter baumannii originating from an intensive care unit. Infect Control Hosp Epidemiol 22, 48–49.[CrossRef]
    [Google Scholar]
  55. Luzzaro, F., Mantengoli, E., Perilli, M., Lombardi, G., Orlandi, V., Orsatti, A., Amicosante, G., Rossolini, G. M. & Toniolo, A. ( 2001; ). Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase. J Clin Microbiol 39, 1865–1870.[CrossRef]
    [Google Scholar]
  56. Maniatis, A. N., Pournaras, S., Orkopoulou, S., Tassios, P. T. & Legakis, N. J. ( 2003; ). Multiresistant Acinetobacter baumannii isolates in intensive care units in Greece. Clin Microbiol Infect 9, 547–553.[CrossRef]
    [Google Scholar]
  57. Maragakis, L. L., Cosgrove, S. E., Song, X. & 7 other authors ( 2004; ). An outbreak of multidrug-resistant Acinetobacter baumannii associated with pulsatile lavage wound treatment. JAMA 292, 3006–3011.[CrossRef]
    [Google Scholar]
  58. Maslow, J. N., Glaze, T., Adams, P. & Lataillade, M. ( 2005; ). Concurrent outbreak of multidrug-resistant and susceptible subclones of Acinetobacter baumannii affecting different wards of a single hospital. Infect Control Hosp Epidemiol 26, 69–75.[CrossRef]
    [Google Scholar]
  59. Michalopoulos, A., Kasiakou, S. K., Rosmarakis, E. S. & Falagas, M. E. ( 2005a; ). Cure of multidrug-resistant Acinetobacter baumannii bacteraemia with continuous intravenous infusion of colistin. Scand J Infect Dis 37, 142–145.[CrossRef]
    [Google Scholar]
  60. Michalopoulos, A. S., Tsiodras, S., Rellos, K., Mentzelopoulos, S. & Falagas, M. E. ( 2005b; ). Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic. Clin Microbiol Infect 11, 115–121.[CrossRef]
    [Google Scholar]
  61. Mirakhur, A., Gallagher, M. J., Ledson, M. J., Hart, C. A. & Walshaw, M. J. ( 2003; ). Fosfomycin therapy for multiresistant Pseudomonas aeruginosa in cystic fibrosis. J Cyst Fibros 2, 19–24.[CrossRef]
    [Google Scholar]
  62. Miranda, G., Leanos, B., Marquez, L., Valenzuela, A., Silva, J., Carrillo, B., Munoz, O. & Solorzano, F. ( 2001; ). Molecular epidemiology of a multiresistant Pseudomonas aeruginosa outbreak in a paediatric intensive care unit. Scand J Infect Dis 33, 738–743.[CrossRef]
    [Google Scholar]
  63. Mussi, M. A., Limansky, A. S. & Viale, A. M. ( 2005; ). Acquisition of resistance to carbapenems in multidrug-resistant clinical strains of Acinetobacter baumannii: natural insertional inactivation of a gene encoding a member of a novel family of beta-barrel outer membrane proteins. Antimicrob Agents Chemother 49, 1432–1440.[CrossRef]
    [Google Scholar]
  64. Oh, J. Y., Kim, K. S., Jeong, Y. W., Cho, J. W., Park, J. C. & Lee, J. C. ( 2002; ). Epidemiological typing and prevalence of integrons in multiresistant Acinetobacter strains. APMIS 110, 247–252.[CrossRef]
    [Google Scholar]
  65. Ohmagari, N., Hanna, H., Graviss, L. & 8 other authors ( 2005; ). Risk factors for infections with multidrug-resistant Pseudomonas aeruginosa in patients with cancer. Cancer 104, 205–212.[CrossRef]
    [Google Scholar]
  66. Oie, S., Uematsu, T., Sawa, A., Mizuno, H., Tomita, M., Ishida, S., Okano, Y. & Kamiya, A. ( 2003; ). In vitro effects of combinations of antipseudomonal agents against seven strains of multidrug-resistant Pseudomonas aeruginosa. J Antimicrob Chemother 52, 911–914.[CrossRef]
    [Google Scholar]
  67. Ortega, B., Groeneveld, A. B. & Schultsz, C. ( 2004; ). Endemic multidrug-resistant Pseudomonas aeruginosa in critically ill patients. Infect Control Hosp Epidemiol 25, 825–831.[CrossRef]
    [Google Scholar]
  68. Paavilainen, T., Alanen, M., Makela, M., Routamaa, M., Jarvinen, H., Huovinen, P. & Kotilainen, P. ( 2001; ). Infrequent isolation of multiresistant Acinetobacter baumannii from the staff tending a colonized patient with severe burns. Infect Control Hosp Epidemiol 22, 388–391.[CrossRef]
    [Google Scholar]
  69. Pagani, L., Colinon, C., Migliavacca, R., Labonia, M., Docquier, J. D., Nucleo, E., Spalla, M., Li Bergoli, M. & Rossolini, G. M. ( 2005; ). Nosocomial outbreak caused by multidrug-resistant Pseudomonas aeruginosa producing IMP-13 metallo-beta-lactamase. J Clin Microbiol 43, 3824–3828.[CrossRef]
    [Google Scholar]
  70. Paramythiotou, E., Lucet, J. C., Timsit, J. F. & 7 other authors ( 2004; ). Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units: role of antibiotics with antipseudomonal activity. Clin Infect Dis 38, 670–677.[CrossRef]
    [Google Scholar]
  71. Pellegrino, F. L., Teixeira, L. M., Carvalho, Md. Mda. G. & 8 other authors ( 2002; ). Occurrence of a multidrug-resistant Pseudomonas aeruginosa clone in different hospitals in Rio de Janeiro, Brazil. J Clin Microbiol 40, 2420–2424.[CrossRef]
    [Google Scholar]
  72. Pimentel, J. D., Low, J., Styles, K., Harris, O. C., Hughes, A. & Athan, E. ( 2005; ). Control of an outbreak of multi-drug-resistant Acinetobacter baumannii in an intensive care unit and a surgical ward. J Hosp Infect 59, 249–253.[CrossRef]
    [Google Scholar]
  73. Pirnay, J. P., De Vos, D., Cochez, C. & 7 other authors ( 2003; ). Molecular epidemiology of Pseudomonas aeruginosa colonization in a burn unit: persistence of a multidrug-resistant clone and a silver sulfadiazine-resistant clone. J Clin Microbiol 41, 1192–1202.[CrossRef]
    [Google Scholar]
  74. Pitten, F. A., Panzig, B., Schroder, G., Tietze, K. & Kramer, A. ( 2001; ). Transmission of a multiresistant Pseudomonas aeruginosa strain at a German University Hospital. J Hosp Infect 47, 125–130.[CrossRef]
    [Google Scholar]
  75. Podnos, Y. D., Cinat, M. E., Wilson, S. E., Cooke, J., Gornick, W. & Thrupp, L. D. ( 2001; ). Eradication of multi-drug resistant Acinetobacter from an intensive care unit. Surg Infect (Larchmt) 2, 297–301.[CrossRef]
    [Google Scholar]
  76. Roberts, S. A., Findlay, R. & Lang, S. D. ( 2001; ). Investigation of an outbreak of multi-drug resistant Acinetobacter baumannii in an intensive care burns unit. J Hosp Infect 48, 228–232.[CrossRef]
    [Google Scholar]
  77. Rossolini, G. M. & Mantengoli, E. ( 2005; ). Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa. Clin Microbiol Infect 11, 17–32.
    [Google Scholar]
  78. Ruiz, J., Navia, M. M., Casals, C., Sierra, J. M., Jimenez De Anta, M. T. & Vila, J. ( 2003; ). Integron-mediated antibiotic multiresistance in Acinetobacter baumannii clinical isolates from Spain. Clin Microbiol Infect 9, 907–911.[CrossRef]
    [Google Scholar]
  79. Saugar, J. M., Alarcon, T., Lopez-Hernandez, S., Lopez-Brea, M., Andreu, D. & Rivas, L. ( 2002; ). Activities of polymyxin B and cecropin A-,melittin peptide CA(1-8)M(1-18) against a multiresistant strain of Acinetobacter baumannii. Antimicrob Agents Chemother 46, 875–878.[CrossRef]
    [Google Scholar]
  80. Schelenz, S. & French, G. ( 2000; ). An outbreak of multidrug-resistant Pseudomonas aeruginosa infection associated with contamination of bronchoscopes and an endoscope washer-disinfector. J Hosp Infect 46, 23–30.[CrossRef]
    [Google Scholar]
  81. Shahid, M., Malik, A. & Sheeba ( 2003; ). Multidrug-resistant Pseudomonas aeruginosa strains harbouring R-plasmids and AmpC beta-lactamases isolated from hospitalised burn patients in a tertiary care hospital of North India. FEMS Microbiol Lett 228, 181–186.[CrossRef]
    [Google Scholar]
  82. Sharma, R., Sharma, C. L. & Kapoor, B. ( 2005; ). Antibacterial resistance: current problems and possible solutions. Indian J Med Sci 59, 120–129.[CrossRef]
    [Google Scholar]
  83. Simor, A. E., Lee, M., Vearncombe, M. & 7 other authors ( 2002; ). An outbreak due to multiresistant Acinetobacter baumannii in a burn unit: risk factors for acquisition and management. Infect Control Hosp Epidemiol 23, 261–267.[CrossRef]
    [Google Scholar]
  84. Smolyakov, R., Borer, A., Riesenberg, K., Schlaeffer, F., Alkan, M., Porath, A., Rimar, D., Almog, Y. & Gilad, J. ( 2003; ). Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment. J Hosp Infect 54, 32–38.[CrossRef]
    [Google Scholar]
  85. Takeyama, K., Kunishima, Y., Matsukawa, M., Takahashi, S., Hirose, T., Kobayashi, N., Kobayashi, I. & Tsukamoto, T. ( 2002; ). Multidrug-resistant Pseudomonas aeruginosa isolated from the urine of patients with urinary tract infection. J Infect Chemother 8, 59–63.[CrossRef]
    [Google Scholar]
  86. Tambic, A. A., Tambic, T., Kalenic, S. & Jankovic, V. ( 2002; ). Surveillance for antimicrobial resistance in Croatia. Emerg Infect Dis 8, 14–18.[CrossRef]
    [Google Scholar]
  87. Tascini, C., Gemignani, G., Ferranti, S., Tagliaferri, E., Leonildi, A., Lucarini, A. & Menichetti, F. ( 2004; ). Microbiological activity and clinical efficacy of a colistin and rifampin combination in multidrug-resistant Pseudomonas aeruginosa infections. J Chemother 16, 282–287.[CrossRef]
    [Google Scholar]
  88. Thong, K. L., Lai, K. S., Ganeswrie, R. & Puthucheary, S. D. ( 2004; ). Pulsed-field gel electrophoresis of multidrug-resistant and -sensitive strains of Pseudomonas aeruginosa from a Malaysian hospital. Jpn J Infect Dis 57, 206–209.
    [Google Scholar]
  89. Tognim, M. C., Andrade, S. S., Silbert, S., Gales, A. C., Jones, R. N. & Sader, H. S. ( 2004; ). Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: five-year report of the SENTRY Antimicrobial Surveillance Program. Int J Infect Dis 8, 284–291.[CrossRef]
    [Google Scholar]
  90. Turton, J. F., Kaufmann, M. E., Warner, M., Coelho, J., Dijkshoorn, L., van der Reijden, T. & Pitt, T. L. ( 2004; ). A prevalent, multiresistant clone of Acinetobacter baumannii in Southeast England. J Hosp Infect 58, 170–179.[CrossRef]
    [Google Scholar]
  91. Urban, C., Segal-Maurer, S. & Rahal, J. J. ( 2003; ). Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii. Clin Infect Dis 36, 1268–1274.[CrossRef]
    [Google Scholar]
  92. van Dessel, H., Dijkshoorn, L., van der Reijden, T., Bakker, N., Paauw, A., van den Broek, P., Verhoef, J. & Brisse, S. ( 2004; ). Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals. Res Microbiol 155, 105–112.[CrossRef]
    [Google Scholar]
  93. Wang, S. H., Sheng, W. H., Chang, Y. Y. & 7 other authors ( 2003; ). Healthcare-associated outbreak due to pan-drug resistant Acinetobacter baumannii in a surgical intensive care unit. J Hosp Infect 53, 97–102.[CrossRef]
    [Google Scholar]
  94. Wilson, S. J., Knipe, C. J., Zieger, M. J., Gabehart, K. M., Goodman, J. E., Volk, H. M. & Sood, R. ( 2004; ). Direct costs of multidrug-resistant Acinetobacter baumannii in the burn unit of a public teaching hospital. Am J Infect Control 32, 342–344.[CrossRef]
    [Google Scholar]
  95. Wood, G. C., Hanes, S. D., Boucher, B. A., Croce, M. A. & Fabian, T. C. ( 2003; ). Tetracyclines for treating multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia. Intensive Care Med 29, 2072–2076.[CrossRef]
    [Google Scholar]
  96. Wu, T. L., Ma, L., Chang, J. C., Su, L. H., Chu, C., Leu, H. S. & Siu, L. K. ( 2004; ). Variable resistance patterns of integron-associated multidrug-resistant Acinetobacter baumannii isolates in a surgical intensive care unit. Microb Drug Resist 10, 292–299.[CrossRef]
    [Google Scholar]
  97. Yoon, J., Urban, C., Terzian, C., Mariano, N. & Rahal, J. J. ( 2004; ). In vitro double and triple synergistic activities of Polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 48, 753–757.[CrossRef]
    [Google Scholar]
  98. Zeana, C., Larson, E., Sahni, J., Bayuga, S. J., Wu, F. & Della-Latta, P. ( 2003; ). The epidemiology of multidrug-resistant Acinetobacter baumannii: does the community represent a reservoir? Infect Control Hosp Epidemiol 24, 275–279.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.46747-0
Loading
/content/journal/jmm/10.1099/jmm.0.46747-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error